Determining thyroid 131I effective half-life for the treatment planning of Graves' disease (2013)
Source: Medical Physics. Unidade: FM
Subjects: DOENÇA DE GRAVES (TERAPIA), DOSIMETRIA, RADIOIMUNOENSAIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLEGAIGNON, José et al. Determining thyroid 131I effective half-life for the treatment planning of Graves' disease. Medical Physics, v. 40, n. 2, p. 022502-1-022502-5, 2013Tradução . . Disponível em: https://doi.org/10.1118/1.4788660. Acesso em: 10 maio 2024.APA
Willegaignon, J., Sapienza, M. T., Coura Filho, G. B., Traino, A. C., & Buchpiguel, C. A. (2013). Determining thyroid 131I effective half-life for the treatment planning of Graves' disease. Medical Physics, 40( 2), 022502-1-022502-5. doi:10.1118/1.4788660NLM
Willegaignon J, Sapienza MT, Coura Filho GB, Traino AC, Buchpiguel CA. Determining thyroid 131I effective half-life for the treatment planning of Graves' disease [Internet]. Medical Physics. 2013 ; 40( 2): 022502-1-022502-5.[citado 2024 maio 10 ] Available from: https://doi.org/10.1118/1.4788660Vancouver
Willegaignon J, Sapienza MT, Coura Filho GB, Traino AC, Buchpiguel CA. Determining thyroid 131I effective half-life for the treatment planning of Graves' disease [Internet]. Medical Physics. 2013 ; 40( 2): 022502-1-022502-5.[citado 2024 maio 10 ] Available from: https://doi.org/10.1118/1.4788660
